По вашему запросу найдено документов: 42

Страница 1 из 5

HOOKAH USE AMONG RUSSIAN ADOLESCENTS: PREVALENCE AND CORRELATES
GALIMOV, A., UNGER, J.B., SUSSMAN, S., EL SHAHAWY, O., MASAGUTOV, R.M. (2019)
) and drug use (alcohol, marijuana, and other illicit drugs), coping strategies, and getting in trouble (self
TREATMENT EFFICACY OF DRUG-RESISTANT TUBERCULOSIS IN BASHKORTOSTAN, RUSSIA: A RETROSPECTIVE COHORT STUDY
Yunusbaeva, M., Borodina, L., Alekseev, P., Davydov, R., Sharipov, R., Bilalov, F., Yunusbayev, B. (2019)
of the highest burdens of drug-resistant tuberculosis. Published data on the drug-resistant tuberculosis
SYNTHESIS AND IN VITRO ANTIBACTERIAL ACTIVITY OF NEW C-3-MODIFIED CARBAPENEMS
VALIULLINA, Z.R., GALEEVA, A.M., GIMALOVA, F.A., SELEZNEVA, N.K., KHASANOVA, L.S., MIFTAKHOV, M.S., MAVZYUTOV, A.R (2019)
-(mercaptoacetyl)methioninate, and 2-(4-methylpiperazin-1-yl)-2-oxoethanethiol as thiols have been used. As a result, we have obtained
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRIS) FOR STROKE RECOVERY
LEGG, L.A., TILNEY, R., HSIEH, C.F., WU, S., LUNDSTRÖM, E., RUDBERG, A.S., KUTLUBAEV, M.A., DENNIS, M., MEAD, G.E., SOLEIMANI, B., BARUGH, A., HACKETT, M.L., HANKEY, G.J (2019)
(SSRIs) have been used for many years to manage depression and other mood disorders after stroke
MOLECULAR DOCKING AND PRECLINICAL STUDY OF FIVE-MEMBERED S,S-PALLADAHETEROCYCLE AS HEPATOPROTECTIVE AGENT
AKHMADIEV, N.S., AKHMETOVA, V.R., IBRAGIMOV, A.G., GALIMOVA, A.M., GALIMOVA, R.A., AGLETDINOV, E.F., KATAEV, V.A., KHAIRULLINA, V.R. (2019)
by molecular docking using LeadIT 2.3.2. Hepatoprotective activity of palladaheterocycle at 2.5, 25 and 250 mg
Afatinib vs Placebo as Adjuvant Therapy After Chemoradiotherapy in Squamous Cell Carcinoma of the Head and Neck: A Randomized Clinical Trial
Burtness, B., Haddad, R., Dinis, J., Trigo, J., Yokota, T, De Souza Viana, L., Romanov, I., Vermorken, J., Bourhis, J., Tahara, M., Martins Segalla, J.G., Psyrri, A., Vasilevskaya, I., Nangia, C.S., Chaves-Conde, M., Kiyota, N., Homma, A., Holeckova, P., Del Campo, J.M., Asarawala, N., Nicolau, U.R., Rauch, D., Even, C., Wang, B., Gibson, N., Ehrnrooth, E., Harrington, K., Cohen, E.E.W. (2019)
.81-1.57; stratified log-rank test P =.48). The most common grade 3 and 4 drug-related adverse effects were acneiform
THE FANCM:P.ARG658* TRUNCATING VARIANT IS ASSOCIATED WITH RISK OF TRIPLE-NEGATIVE BREAST CANCER
Bogliolo, M., Catucci, I., Caleca, L., Lasheras, S.V., Pujol, R., Kiiski, J.I., Muranen, T.A., Barnes, D.R., Dennis, J., Michailidou, K., Bolla, M.K., Leslie, G., Figlioli, G. (2019)
unclassified drug
OPENING UP NEW HORIZONS FOR PSYCHIATRIC GENETICS IN THE RUSSIAN FEDERATION: MOVING TOWARD A NATIONAL CONSORTIUM
Fedorenko, O.Y., Golimbet, V.E., Ivanova, S.А., Levchenko, А., Gainetdinov, R.R., Semke, A.V., Simutkin, G.G., Gareeva, А.E., Glotov, А.S., Gryaznova, A., Iourov, I.Y., Krupitsky, E.M., Lebedev, I.N., Mazo, G.E., Kaleda, V.G., Abramova, L.I., Oleichik, I.V., Nasykhova, Y.A., Nasyrova, R.F., Nikolishin, A.E., Kasyanov, E.D., Rukavishnikov, G.V., Timerbulatov, I.F., Brodyansky, V.M., Vorsanova, S.G., Yurov, Y.B., Zhilyaeva, T.V., Sergeeva, A.V., Blokhina, E.A., Zvartau, E.E., Blagonravova, A.S., Aftanas, L.I., Bokhan, N.А., Kekelidze, Z.I., Klimenko, T.V., Anokhina, I.P., Khusnutdinova, E.K., Klyushnik, T.P., Neznanov, N.G., Stepanov, V.A., Schulze, T.G., Kibitov, А.О. (2019)
DRUG
The role of genetic factors in levodopa-induced dyskinesias development in Russian patients with Parkinson's disease: A pilot study
Akhmadeeva, G., Khidiyatova, I., Gilyazova, I., Baitimerov, A., Magzhanov, R. (2019)
Levodopa is the most effective drug for the treatment of Parkinson's disease (PD). After about 5
Cloud technologies and machine learning in malignant tumors identification via Raman spectroscopy
KOVTUNENKO, A.S., BILYALOV, A.R., V.N. Pavlov (2019)
the technical aspects of solving the problem of malignant tumors diagnostic using machine learning

Страница 1 из 5

Google Scholar
OpenDoar

Фасеты

Авторы
Ключевые слова
Год